Business
Result of Placing and PrimaryBid offer
Result of Placing and PrimaryBid offer.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0505A\n Oxford Biomedica PLC\n 28 January 2022\n \n \n \n \n 28 January 2022\n \n \n THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED IN THEM, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.\n \n \n FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN OXFORD BIOMEDICA PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF OXFORD BIOMEDICA PLC.\n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.\n \n \n \n LEI: \n \n 213800S1GVQNXQ15K851\n \n \n \n \n \n OXFORD BIOMEDICA PLC\n \n \n (\"Oxford Biomedica\" or the \"Company\")\n \n \n Result of Placing and PrimaryBid offer\n \n \n Oxford, UK - 28 January 2022: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy group, is pleased to announce the successful completion of the proposed placing announced earlier today (the \"Placing\"). \n \n \n A total of 9,876,544 new ordinary shares of fifty pence each in the capital of the Company (the \"Placing Shares\") have been conditionally placed by Peel Hunt LLP (\"Peel Hunt\") and WG Partners LLP (\"WG\") (together, the \"Joint Bookrunners\") with new and existing investors at a price of 810 pence per Placing Share (the \"Placing Price\") raising gross proceeds of £80.0 million for the Company. The Placing Shares represent 11.5 per cent. of the issued ordinary share capital of the Company prior to the Placing.\n \n \n The Placing is being conducted in two tranches:\n \n \n ·\n A firm placing allocation of 4,858,410 new ordinary shares in the Company (the \"Firm Placing Shares\") equating to 5.6% of the Company's existing iss...